Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving closer to approval. The opioid epidemic in the ...

agonist in phase 1 testing that also has potential as a non-opioid painkiller. Lilly's Zepbound has become the first drug approved by the FDA for obese patients with obstructive sleep apnoea ...

Vertex Pharmaceuticals said on Thursday its experimental non-opioid drug met the main goal of a mid-stage study but showed ...

They're pressing ahead with a Phase 3 trial, banking on tweaks to trial designs to tackle what they're calling a placebo ...

A 2017 study recommends rotating through classes of opioids, staying on the lowest possible dosage, and combining opioids with non-opioid painkillers. Titrating (building up) to higher doses slowly ...

Vertex Pharmaceuticals reported that its non-opioid drug reduced back pain significantly. But Vertex stock plunged as a ...

The market for non-opioid painkillers is booming in the wake of a devastating overdose crisis and an opioid industry far ...

The Ministry of Food and Drug Safety announced on the 12th that it has granted item approval for Anapra (generic name: Opiranzeline), a non-narcotic pain reliever developed by Bicon Pharma.

INR:1955. kerala november yearly chart Heron's new non-opioid painkiller gets 3-month extension in U.S. review GSP certification will be cancelled in ...

A Georgia House study committee discussed recommendations for non-opioid pain relief Thursday aimed at addressing opioid addiction.

The new combination, dubbed Alyftrek, is designed to improve on the Trikafta, a product that generated sales of $8.9 billion ...